ABUSのPER（株価収益率）は？

ARBUTUS BIOPHARMA CORP（ABUS）は現在PER 5.06倍で取引されています。

ABUSのROE（自己資本利益率）は？

ARBUTUS BIOPHARMA CORPのROEは61.77%です。

ABUSの配当利回りは？

ARBUTUS BIOPHARMA CORPの配当利回りは0.00%です。

ABUSの品質スコア（Quality Score）は？

当社のAIはABUSの総合財務品質を100点中69点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ABUSは今が買い時ですか？

当社AIのタイミングスコアは100点中56点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ABUSはどのセクターに属しますか？

ARBUTUS BIOPHARMA CORPはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ABUS (NASDAQ) 株価分析 | ARBUTUS BIOPHARMA CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ABUS AI Analysis Summary

Our AI summary for ABUS: ARBUTUS BIOPHARMA CORP (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 5.06, ROE of 61.77%, a dividend yield of 0.00%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 56/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ABUS

ARBUTUS BIOPHARMA CORP

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 4.34

-0.07 (-1.59%) Day Change

Watchlist Portfolio Compare Chart

5.06

P/E

0.00

D/E

61.8%

ROE

58.0%

ROA

0.00%

Div Yield

ARBUTUS BIOPHARMA CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.34 Price -0.07 (-1.59%) Day Change	NEWS SCORE: N/A

ABUS, ファンダメンタルスコアはok ( ファンダメンタル = 69) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

69 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.34
PBV / Sector	3.35 / 5.20
Earning Per Share	0.80

PE / Sector	5.06 / 19.97 GREAT
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	9.34 M
Average 1W Daily Value	4.91 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	83.95 / 98.71 GREAT
NPM Average (%) / Sector	-373.31 / -1,721.76
NPM Change Average (%) / Sector	23.36 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	57.99 / 27.02 GREAT
ROA Average (%) / Sector	-23.30 / -368.17
ROA Change Average (%) / Sector	-62.48 / 5,404.12
ROE (%) / Sector	61.77 / 3.47 GREAT
ROE Average (%) / Sector	-34.65 / 6.51
ROE Change Average (%) / Sector	-60.10 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 07:59:25
Symbol	ABUS
Name	ARBUTUS BIOPHARMA CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	197.54 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	871.14 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 701 Veterans Circle, Warminster, PA, United States, 18974

Phone: 267 469 0914

Website: https://www.arbutusbio.com

Sector: Healthcare >> Biotechnology

Description: Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients' HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.